Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-18 · accession 0001493152-22-014518 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-19 | 2022-05-18 | IMDX | Yu Li | VP Cntrllr, Prncpl Acctng Offcr | M - OptEx | $0.00 | +25.0K | 25.0K | New | $0 |
| D | 2022-05-19 | 2022-05-18 | IMDX | Yu Li | VP Cntrllr, Prncpl Acctng Offcr | S - Sale+OE | $1.14 | -8,128 | 16.9K | -33% | -$9,266 |
| D | 2022-05-19 | 2022-05-18 | IMDX | Yu Li | VP Cntrllr, Prncpl Acctng Offcr | M - OptEx | $0.00 | -25.0K | 25.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-05-18 | M | A | 25,000 | $0.00 | 25,000 | D | — | — | |
| 2 | Common | Common Stock, no par value | 2022-05-18 | S | D | 8,128 | $1.14 | 16,872 | D | — | — | (F1) Represents shares sold to cover the tax liability arising from the vesting of Restricted Stock Units. |
| 3 | Derivative | Restricted Stock Units | 2022-05-18 | M | D | 25,000 | $0.00 | 25,000 | D | $0.00 · — to — | 25,000 Common Stock | (F2) Restricted Stock Units vested on May 18, 2022. |